Venus Remedies' Tobracef gets South African patent
Venus Remedies Limited, a Haryana-based leading research based company, has announced that the company has received patent for Tobracef from the Companies and Intellectual Property Registration Office (CIPRO), South Africa.
Tobracef is indicated for the treatment of complicated mixed bacterial infection of acute pulmonary exacerbations/custic fibrosis/chronic obstructive pulmonary disease. The product is a novel fixed dose combination of cephalosporin and aminoglycoside.
Comments